Juniper Pharma Cash Flow - Annual (NASDAQ:JNP)

Add to My Stocks
$11.5 $0 (0%) JNP stock closing price Aug 14, 2018 (Closing)

For analyzing any company like Juniper Pharma from an investment perspective, its important to check the cash flow statement. The profit-loss statement shows Juniper Pharma profits, the balance sheet shows Juniper Pharma debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Juniper Pharma saw a cash impact of $- from the buyback of JNP shares. The cash flow statement helps in the Juniper Pharma stock analysis by providing more information for evaluating changes in assets, liabilities and equities. Juniper Pharma has a negative cash and cash equivalents change of $-.

View details of Juniper Pharma cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow2.25M1.89M1.91M1.99M---4.75M8.62M8.06M
Net Increase (Decrease) in Assets Liabilities-2.13M-2.41M--0.28M-1.13M-5.79M--0.95M-1.44M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net1.46M1.2M1.75M--0.26M-5.08M-16.23M6.8M5.14M2.31M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-2.84M-3.56M-1.7M-2.04M-0.52M-0.98M-1.3M35.19M-0.04M-0.37M
Acquisition Disposition of Subsidiaires-----14.51M-----
Increase (Decrease) in Investments----15.35M-0.23M-15.1M---
Other Cash Inflow (Outflow) from Investment Activities------3.1M---
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares----8.47M--0.05M3.16M8.6M11.36M4.55M
Issuance (Repayment) of Debt Securities1.05M-0.22M-0.23M-0.24M-0.07M---27.15M--3.54M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions-0.01M-0.02M-0.02M-0.02M-0.02M-0.02M-0.03M-0.03M-0.03M-0.05M
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash--0.27M-0.05M-0.08M---0.01M-0.01M--0.17M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year20.99M13.9M16.76M20.71M13.2M10.11M21.63M14.75M12.49M17.22M
Cash & Equivalents at Year End21.44M20.99M13.9M16.76M20.71M13.2M10.11M21.63M14.75M12.49M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

While Juniper Pharma stock price history provides the price history of a stock, Juniper Pharma stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Juniper Pharma has cash of $21.44M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Juniper Pharma stock price.
  • Cash Flow from operating activities: Juniper Pharma reported a positive operating cash flow of $2.12M for 2017 and has seen a decrease from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: Juniper Pharma used $-2.84M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Juniper Pharma earned $1.03M from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Juniper Pharma Cash Flow

FCF margin